1978
DOI: 10.1007/bf01228133
|View full text |Cite
|
Sign up to set email alerts
|

Metabolic abnormalities during combined sulphonylurea and phenformin therapy in maturity-onset diabetics

Abstract: Twelve hour metabolic rhythms have been determined in two groups of subjects during combined therapy with a sulphonylurea and phenformin 50 mg twice daily. Subjects with clinical evidence of complications of diabetes showed greater abnormalities in concentrations of blood intermediary metabolites than a group of subjects without complications despite similar mean blood glucose concentrations in the two groups (7.6 mmol/1 with complications; 7.3 mmol/1 without complications). Mean blood lactate (1.93 mmol/1 v 1… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

1979
1979
1993
1993

Publication Types

Select...
3
2

Relationship

1
4

Authors

Journals

citations
Cited by 6 publications
(1 citation statement)
references
References 18 publications
0
1
0
Order By: Relevance
“…Little attention has been paid, however, to abnormalities of other intermediary metabolites in untreated Type 2 diabetic patients and the response of these to treatment. In previous studies of Type 2 diabetic patients treated with sulphonylureas [4] or biguanide therapy [5,6], abnormalities of circulating intermediary metabolite concentrations were found, although the therapeutic and prognostic importance of these abnormalities is not known [7]. We have studied the response of blood concentrations of the gluconeogenic precursors, lactate, pyruvate, alanine and glycerol, and the ketone body, 3-hydroxybutyrate, in Type 2 diabetic patients for 4 h following a standard breakfast, at diagnosis and following correction of hyperglycaemia by a period of diet.…”
mentioning
confidence: 99%
“…Little attention has been paid, however, to abnormalities of other intermediary metabolites in untreated Type 2 diabetic patients and the response of these to treatment. In previous studies of Type 2 diabetic patients treated with sulphonylureas [4] or biguanide therapy [5,6], abnormalities of circulating intermediary metabolite concentrations were found, although the therapeutic and prognostic importance of these abnormalities is not known [7]. We have studied the response of blood concentrations of the gluconeogenic precursors, lactate, pyruvate, alanine and glycerol, and the ketone body, 3-hydroxybutyrate, in Type 2 diabetic patients for 4 h following a standard breakfast, at diagnosis and following correction of hyperglycaemia by a period of diet.…”
mentioning
confidence: 99%